Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · IEX Real-Time Price · USD

6.49

+0.62 (10.56%)

At close: May 2, 2024, 4:00 PM

5.33

-1.16 (-17.87%)

After-hours: May 3, 2024, 4:21 PM EDT

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	69	300	437	-	-	-
Market Cap Growth	-	-31.47%	-	-	-	-
Enterprise Value	58	289	422	4	3	2
PE Ratio	-51.07	-51.07	-58.75	-	-	-
PB Ratio	5.77	24.92	25.64	-	-	-
P/FCF Ratio	-60.09	-60.09	-72.34	-	-	-
P/OCF Ratio	-60.41	-60.41	-83.06	-	-	-
EV/EBITDA Ratio	-56.59	-56.59	-61.66	-2.74	-3.34	-4.70
EV/EBIT Ratio	-49.18	-49.18	-56.65	-2.69	-3.30	-4.70
EV/FCF Ratio	-57.87	-57.87	-69.75	-4.72	-3.18	-4.70
Debt / Equity Ratio	0.04	0.04	0.05	-0.92	-1.16	-1.13
Debt / EBITDA Ratio	-0.09	-0.09	-0.11	-2.79	-3.82	-5.32
Debt / FCF Ratio	-0.09	-0.09	-0.13	-4.80	-3.64	-5.32
Quick Ratio	19.15	19.15	28.46	0.02	0.12	0.12
Current Ratio	19.15	19.15	28.46	0.02	0.12	0.12
Return on Equity (ROE)	-40.40%	-40.40%	-114.00%	40.50%	36.20%	-
Return on Assets (ROA)	-38.30%	-38.30%	-81.10%	-315.30%	-214.50%	-
Return on Capital (ROIC)	-50.21%	-50.21%	-42.71%	437.60%	-193.87%	-160.70%
Earnings Yield	-8.46%	-1.96%	-1.70%	-	-	-
FCF Yield	-7.19%	-1.66%	-1.38%	-	-	-
Buyback Yield / Dilution	-1.62%	-1.62%	-28.06%	-	-	-
Total Shareholder Return	-1.62%	-1.62%	-28.06%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).